Submit additional data: CDSCO Tells Laurus Labs to on Carglumic acid dispersible tablets Dr. Divya Colin17 July 2023 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended the drug major...
Laurus Labs, IIT Kanpur ink pact for novel gene therapy assets Ruchika Sharma20 Jun 2023 2:30 PM ISTHyderabad: Laurus Labs Ltd. has signed an MOA with IIT Kanpur (IITK) to bring novel gene therapy assets to market.As per MOA, Laurus labs will...
Laurus Labs gets USFDA EIR for Visakhapatnam facility Ruchika Sharma16 Jun 2023 12:30 PM ISTHyderabad: Laurus Labs has announced that the Company has received the Establishment Inspection Report (EIR) from the United States Food &...
Laurus Labs to buy additional stake of 7.24 percent in Immunoadoptive Cell Therapy for Rs 80 Crore Ruchika Sharma1 Jun 2023 1:00 PM ISTAdditionally, some promoters and senior management of Laurus Labs would also acquire in ImmunoACT for a 0.54% stake (before this investment) for...
Laurus Labs bags USFDA nod for Paediatric ARV Oral Dispersible Film drug Dolutegravir in HIV/AIDS treatment Ruchika Sharma2 May 2023 4:24 PM ISTHyderabad: Laurus Labs Ltd., a R&D driven pharmaceutical & biotech manufacturing company in India, has announced the receipt of the US Food...
Submit revised BE study protocol: CDSCO panel tells Laurus Labs on Carglumic Acid Dispersible Tablets Dr. Divya Colin25 March 2023 5:45 PM ISTNew Delhi: Rejecting drug maker Laurus Lab's proposal for clinical trial waiver of Carglumic acid dispersible tablets 200mg, the subject committee...
Laurus Labs gets 2 USFDA observations for Visakhapatnam facility Ruchika Sharma11 Feb 2023 1:15 PM ISTTelangana: Laurus Labs has announced that the company has received Form 483 with two observations from the US Food and Drug Administration (USFDA)...
Laurus Labs reports 32.1 percent rise in Q3 profit Ruchika Sharma31 Jan 2023 11:00 AM ISTBengaluru: India's Laurus Labs Ltd reported a 32.1 percent rise in third-quarter profit on Monday, boosted by strong demand in its businesses that...
Laurus Lab gets CDSCO panel nod to Manufacture, Market HIV drug Dolutegravir Sodium Oral Film Dr. Divya Colin15 Jan 2023 5:00 PM ISTNew Delhi: In line with the bioequivalence study data presented by drug maker Laurus Lab, the Subject Expert Committee (SEC) functional under the...
Laurus Labs gets 1 USFDA observation for Visakhapatnam facility Ruchika Sharma29 Oct 2022 3:32 PM ISTHyderabad: Laurus Labs today announced that the US Food and Drug Administration (USFDA) has concluded a PreApproval Inspection (PAI) with...
Meet 52 richest Indians in Pharma Healthcare domain Farhat Nasim21 Sept 2022 7:33 PM ISTNew Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun...
Laurus Labs inks pact with MPP to manufacture molnupiravir Medical Dialogues Bureau22 Jan 2022 3:52 PM ISTNew Delhi: Drug firm Laurus Labs on Friday said it has inked a pact with Geneva-based MPP (Medicine Patient Pool) for manufacturing the oral COVID-19...
